Open AccessThis article is
- freely available
Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221 005, India
* Author to whom correspondence should be addressed.
Received: 15 November 2010; Accepted: 15 December 2010 / Published: 20 December 2010
Abstract: Antimony toxicity occurs either due to occupational exposure or during therapy. Occupational exposure may cause respiratory irritation, pneumoconiosis, antimony spots on the skin and gastrointestinal symptoms. In addition antimony trioxide is possibly carcinogenic to humans. Improvements in working conditions have remarkably decreased the incidence of antimony toxicity in the workplace. As a therapeutic, antimony has been mostly used for the treatment of leishmaniasis and schistosomiasis. The major toxic side-effects of antimonials as a result of therapy are cardiotoxicity (~9% of patients) and pancreatitis, which is seen commonly in HIV and visceral leishmaniasis co-infections. Quality control of each batch of drugs produced and regular monitoring for toxicity is required when antimonials are used therapeutically.
Keywords: antimony; toxicity; leishmaniasis; occupational hazard
Citations to this Article
Cite This Article
MDPI and ACS Style
Sundar, S.; Chakravarty, J. Antimony Toxicity. Int. J. Environ. Res. Public Health 2010, 7, 4267-4277.
Sundar S, Chakravarty J. Antimony Toxicity. International Journal of Environmental Research and Public Health. 2010; 7(12):4267-4277.
Sundar, Shyam; Chakravarty, Jaya. 2010. "Antimony Toxicity." Int. J. Environ. Res. Public Health 7, no. 12: 4267-4277.